Characterization and Antiatherogenic Potential of P3R99 Monoclonal Antibody Against Sulfated Glycosaminoglycans: Physicochemical and Functional Insights
Leidy Marian Valencia, Yoandra Martínez-Montano, José Alberto Gómez, Roger Sarduy, Arletty Hernández, Spencer D. Proctor, Aymé Fernández-Calienes, Víctor Brito, Yosdel Soto
This study characterizes P3R99 monoclonal antibody variants from different cell lines and shows they retain antiatherogenic properties despite structural differences.
bioRxiv · Sep 9, 2024 · PreprintImmunology